歐洲急性胰臟炎市場預測至 2030 年 - 區域分析 - 按產品、原因和最終用戶

2022年歐洲急性胰臟炎市值為14.921億美元，預計到2030年將達到22.6069億美元；預計 2022 年至 2030 年CAGR為 5.3%。

急性胰臟炎後糖尿病發生率上升推動歐洲急性胰臟炎市場

胰臟產生胰島素，一種調節血糖水平的荷爾蒙。胰臟炎會損害胰臟產生胰島素的細胞，進而導致急性胰臟炎患者罹患糖尿病。患有急性胰臟炎的人患糖尿病的風險是一般人群的兩倍。在急性胰臟炎的各種嚴重程度中都觀察到糖尿病後遺症，並且可能伴隨其他臨床併發症。

根據2022年發布的《歐洲醫學和藥理學科學評論》，西方糖尿病人群中胰源性糖尿病的盛行率為5-10%，其中慢性胰臟炎佔20%，急性胰臟炎佔80%。根據 2021 年國家醫學圖書館發表的一篇文章，約 23% 的急性胰臟炎患者可能在出院三年內患有糖尿病。此外，2020 年《胃腸病學雜誌》上發表的一篇文章指出，急性胰臟炎後，約有3%、7%、9% 和11% 的患者在出院6、12、18 和24 個月時分別發展為糖尿病。根據 MDPI 發表的一篇文章，到 2023 年，約 40% 的急性胰臟炎患者受到糖尿病前期和糖尿病的影響，死亡和再入院的風險比第 2 型糖尿病患者更高。此外，大約 60.2% 的成人患者在急性胰臟炎後發展為糖尿病，9% 的兒童在急性復發性胰臟炎或慢性胰臟炎後發展為糖尿病，而且這種風險隨著年齡的成長而增加。研究人員在一項比較重症和輕度急性胰臟炎的統合分析中發現，重症急性胰臟炎後糖尿病的發生率（約 39%）高於輕度急性胰臟炎（14%）。因此，急性胰臟炎患者或復健患者中糖尿病發病率的增加促進了歐洲急性胰臟炎市場的成長。

歐洲急性胰臟炎市場概況

歐洲急性胰臟炎市場分為德國、英國、法國、義大利、西班牙、北歐國家、荷蘭和歐洲其他國家。德國和英國等國家預計將成為該地區市場的最大貢獻者。急性胰臟炎盛行率的上升和酒精消費的增加是推動歐洲市場成長的主要因素。根據聯邦統計局的數據，2019年德國的醫療支出達4,600.3億美元。由於其創新的醫療保健方法，對於提供急性胰臟炎治療產品的公司來說，這是一個有吸引力的市場。德國的醫療器材製造商還可以為各種研究計畫尋求政府資助，並獲得德國復興信貸銀行 (KfW) 的資助。製造商越來越關注新產品開發和策略合作，以開發急性胰臟炎等先進診斷設備，預計將在未來幾年進一步推動市場成長。

歐洲急性胰臟炎市場收入及 2030 年預測（百萬美元）

歐洲急性胰臟炎市場細分

歐洲急性胰臟炎市場按產品、原因、最終用戶和國家進行細分。

根據產品類型，歐洲急性胰臟炎市場分為藥物、診斷等。 2022年，診斷細分市場佔據最大市場佔有率。

根據方法，歐洲急性胰臟炎市場分為膽結石、酗酒、遺傳性疾病、感染等。 2022 年，膽結石細分市場佔據最大的市場佔有率。

根據最終用戶，歐洲急性胰臟炎市場分為醫院、診斷實驗室、門診手術中心等。 2022 年，醫院細分市場佔據最大市場佔有率。

根據國家/地區，歐洲急性胰臟炎市場分為英國、德國、法國、義大利、西班牙、北歐國家、荷蘭和歐洲其他國家。 2022年，德國在歐洲急性胰臟炎市場佔有率中佔據主導地位。

Abbott Laboratories、Actim Oy、Baxter International Inc、Boston Scientific Corp、Dynavax Technologies Corp、Fresenius Kabi AG、GE HealthCare Technologies Inc、Koninklijke Philips NV、Medtronic Plc 和 Samsung Healthcare 是歐洲急性胰臟炎市場上的一些領先公司。

主要市場促進因素
- 急性胰臟炎導致胰臟癌病例增加
- 急性胰臟炎後糖尿病發生率上升
主要市場限制
- 胰臟炎和胰臟癌治療的副作用
主要市場機會
- 急性胰臟炎的研發活動和宣傳項目數量激增
未來的趨勢
- 特異性急性胰臟炎治療的進展
影響分析：

第 6 章：急性胰臟炎市場 - 歐洲市場分析

歐洲急性胰臟炎市場收入，2022 - 2030

第 7 章：歐洲急性胰臟炎市場 - 收入和 2030 年預測 - 按產品分類

概述
2022 年及 2030 年歐洲急性胰臟炎市場收入佔有率（按產品分類）（%）
藥物
診斷
其他

第 8 章：歐洲急性胰臟炎市場 - 收入和 2030 年預測 - 按原因

概述
2022 年及 2030 年歐洲急性胰臟炎市場收入佔有率（按原因分類）（%）
膽結石
酗酒
遺傳性疾病
感染
其他

第 9 章：歐洲急性胰臟炎市場 - 收入和 2030 年預測 - 按最終用戶

概述
2022 年及 2030 年歐洲急性胰臟炎市場收入佔有率（按最終用戶）（%）
醫院
診斷實驗室
門診手術中心
其他

第 10 章：歐洲急性胰臟炎市場 - 國家分析

概述

第 11 章：歐洲急性胰臟炎市場-產業格局

概述
歐洲急性胰臟炎市場的成長策略
無機成長策略
- 概述
有機成長策略
- 概述

第 12 章：公司簡介

Abbott Laboratories
GE HealthCare Technologies Inc
Samsung Healthcare
Koninklijke Philips NV
Baxter International Inc
Dynavax Technologies Corp
Actim Oy
Medtronic Plc
Boston Scientific Corp
Fresenius Kabi AG

第 13 章：附錄

Product Code: BMIRE00029223

The Europe acute pancreatitis market was valued at US$ 1,492.10 million in 2022 and is expected to reach US$ 2,260.69 million by 2030; it is estimated to grow at a CAGR of 5.3% from 2022 to 2030.

Rising Incidence of Diabetes Following Acute Pancreatitis Fuels the Europe Acute Pancreatitis Market

The pancreas produces insulin, a hormone that regulates blood sugar levels. Pancreatitis can harm insulin-producing cells of pancreas, which causes diabetes in patients suffering from acute pancreatitis. People suffering from acute pancreatitis are at a twofold greater risk of diabetes as compared to the general population. Diabetes sequelae are observed across the spectrum of severity in acute pancreatitis and can accompany other clinical complications.

As per the European Review for Medical and Pharmacological Sciences, published in 2022, the prevalence of pancreatogenic diabetes is 5-10% in the Western diabetic population, and chronic pancreatitis is responsible for 20% of cases while acute pancreatitis causes 80% of cases. According to an article published in the National Library of Medicine in 2021, ~23% of acute pancreatitis patients are likely to develop diabetes within three years of discharge. Further, an article published in the Journal of Gastroenterology in 2020 states that following acute pancreatitis, ~3%, 7%, 9%, and 11% of patients develop diabetes at 6, 12, 18, and 24 months of discharge, respectively. According to an article published in the MDPI, in 2023, ~40% of patients with acute pancreatitis are affected by prediabetes and diabetes and are at a higher risk of death and readmission to hospitals than patients with type 2 diabetes. Further, ~ 60.2% of adult patients developed diabetes after acute pancreatitis, and 9% of children after acute recurrent pancreatitis or with chronic pancreatitis, and this risk increases as they age into adulthood. Researchers have noted higher diabetes incidence (~39%) after severe acute pancreatitis than mild acute pancreatitis (14%) in a meta-analysis comparing severe and mild acute pancreatitis. Thus, the increasing incidence of diabetes in patients suffering or recovering from acute pancreatitis contributes to the growth of the Europe acute pancreatitis market.

Europe Acute Pancreatitis Market Overview

The Europe acute pancreatitis market is segmented into Germany, the UK, France, Italy, Spain, Nordic Countries, The Netherlands, and the Rest of Europe. Countries such as Germany and the UK are expected to be the largest contributors to the market in this region. The rising prevalence of acute pancreatitis and increase in alcohol consumption are the major factors driving the market growth in Europe. According to the Federal Statistical Office, health expenditure in Germany amounted to US$ 460.03 billion in 2019. It is an attractive market for companies offering therapeutic products for acute pancreatitis due to its innovative approach toward healthcare. Medical device manufacturers in Germany can also seek government funding for a variety of research projects and receive grants from the Kreditanstalt fur Wiederaufbau (KfW). The increasing focus of manufacturers on new product development and strategic collaborations to develop advanced diagnostic devices such as acute pancreatitis is expected to further propel the market growth in the coming years.

Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

Europe Acute Pancreatitis Market Segmentation

The Europe acute pancreatitis market is segmented offerings, causes, end user, and country.

Based on offerings, the Europe acute pancreatitis market is segmented into medications, diagnosis, and others. The diagnosis segment held the largest market share in 2022.

Based on method, the Europe acute pancreatitis market is segmented into gallstones, alcoholism, genetic disorders, infection, and others. The gallstones segment held the largest market share in 2022.

Based on end user, the Europe acute pancreatitis market is divided into hospitals, diagnostic laboratories, ambulatory surgical centres, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Europe acute pancreatitis market is segmented into the U.K., Germany, France, Italy, Spain, the Nordic Countries, the Netherlands, and the Rest of Europe. Germany dominated the Europe acute pancreatitis market share in 2022.

Abbott Laboratories, Actim Oy, Baxter International Inc, Boston Scientific Corp, Dynavax Technologies Corp, Fresenius Kabi AG, GE HealthCare Technologies Inc, Koninklijke Philips NV, Medtronic Plc, and Samsung Healthcare are some of the leading companies operating in the Europe acute pancreatitis market.

5.1 Key Market Drivers
- 5.1.1 Rise in Pancreatic Cancer Cases Due to Acute Pancreatitis
- 5.1.2 Rising Incidence of Diabetes Following Acute Pancreatitis
5.2 Key Market Restraints
- 5.2.1 Side Effects of Pancreatitis and Pancreatic Cancer Treatments
5.3 Key Market Opportunities
- 5.3.1 Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis
5.4 Future Trends
- 5.4.1 Advancements in Specific Acute Pancreatitis Treatments
5.5 Impact Analysis:

6. Acute Pancreatitis Market - Europe Market Analysis

6.1 Europe Acute Pancreatitis Market Revenue (US$ Mn), 2022 - 2030

7. Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Offerings

7.1 Overview
7.2 Europe Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
7.3 Medications
- 7.3.1 Overview
- 7.3.2 Medications: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.3.2.1 Europe Acute Pancreatitis Market, by Medications, 2020-2030 (US$ Million)
7.4 Diagnosis
- 7.4.1 Overview
- 7.4.2 Diagnosis: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.4.2.1 Europe Acute Pancreatitis Market, by Diagnosis, 2020-2030 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Causes

8.1 Overview
8.2 Europe Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
8.3 Gallstones
- 8.3.1 Overview
- 8.3.2 Gallstones: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Alcoholism
- 8.4.1 Overview
- 8.4.2 Alcoholism: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Genetic Disorders
- 8.5.1 Overview
- 8.5.2 Genetic Disorders: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Infections
- 8.6.1 Overview
- 8.6.2 Infections: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 Europe Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Diagnostic Laboratories
- 9.4.1 Overview
- 9.4.2 Diagnostic Laboratories: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Ambulatory Surgical Centers
- 9.5.1 Overview
- 9.5.2 Ambulatory Surgical Centers: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Acute Pancreatitis Market - Country Analysis

10.1 Overview

11. Europe Acute Pancreatitis Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Europe Acute Pancreatitis Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Abbott Laboratories
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 GE HealthCare Technologies Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Samsung Healthcare
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Koninklijke Philips NV
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Baxter International Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Dynavax Technologies Corp
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Actim Oy
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Medtronic Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Boston Scientific Corp
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Fresenius Kabi AG
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

List Of Tables

Table 1. Europe Acute Pancreatitis Market Segmentation
Table 2. Europe Acute Pancreatitis Market, by Medications - Revenue and Forecast to 2030 (US$ Million)
Table 3. Europe Acute Pancreatitis Market, by Diagnosis - Revenue and Forecast to 2030 (US$ Million)
Table 4. UK: Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 5. UK: Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 6. UK: Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 7. UK: Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 8. UK: Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 9. Germany: Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 10. Germany: Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 11. Germany: Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 12. Germany: Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 13. Germany: Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. France: Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 15. France: Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 16. France: Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 17. France: Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 18. France: Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 19. Italy: Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 20. Italy: Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 21. Italy: Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 22. Italy: Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 23. Italy: Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 24. Spain: Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 25. Spain: Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 26. Spain: Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 27. Spain: Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 28. Spain: Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 29. Nordic Region: Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 30. Nordic Region: Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 31. Nordic Region: Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 32. Nordic Region: Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 33. Nordic Region: Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 34. Netherlands: Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 35. Netherlands: Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 36. Netherlands: Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 37. Netherlands: Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 38. Netherlands: Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 39. Rest of Europe: Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 40. Rest of Europe: Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 41. Rest of Europe: Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 42. Rest of Europe: Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 43. Rest of Europe: Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 44. Recent Inorganic Growth Strategies in the Europe Acute Pancreatitis Market
Table 45. Recent Organic Growth Strategies in the Europe Acute Pancreatitis Market
Table 46. Glossary of Terms, Europe Acute Pancreatitis Market

List Of Figures

Figure 1. Europe Acute Pancreatitis Market Segmentation, By Country
Figure 2. Europe Acute Pancreatitis Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Acute Pancreatitis Market Revenue (US$ Mn), 2022 - 2030
Figure 5. Europe Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
Figure 6. Medications: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Diagnosis: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Europe Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
Figure 10. Gallstones: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Alcoholism: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Genetic Disorders: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Infections: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Europe Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 16. Hospitals: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Diagnostic Laboratories: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Ambulatory Surgical Centers: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Europe Acute Pancreatitis Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 21. Europe Acute Pancreatitis Market, By Key Countries, 2022 and 2030 (%)
Figure 22. UK: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Germany: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. France: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Italy: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Spain: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Nordic Region: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Netherlands: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Rest of Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Growth Strategies in the Europe Acute Pancreatitis Market

歐洲急性胰臟炎市場預測至 2030 年 - 區域分析 - 按產品、原因和最終用戶

Europe Acute Pancreatitis Market Forecast to 2030 - Regional Analysis - by Offerings, Causes, and End User

目錄

第 1 章：簡介

第 2 章：執行摘要

第 3 章：研究方法

第 4 章：歐洲急性胰臟炎市場格局

第 5 章：歐洲急性胰臟炎市場 - 主要產業動態